Literature DB >> 3411461

Protein binding of ceftriaxone in extravascular fluids.

P J McNamara1, V Trueb, K Stoeckel.   

Abstract

Ceftriaxone binding in extravascular fluids and diluted plasma was characterized by equilibrium dialysis techniques and the data was subjected to Scatchard analysis. The extent of ceftriaxone binding in extravascular fluids (synovial, lymph, ascites, and pleural exudate) was less than plasma due primarily to lower albumin concentrations. Ceftriaxone capacity constants were highly correlated (r2 = 0.900, p less than 0.001) with measured albumin concentrations (range of 43 g/L for albumin to 4.7 g/L for one of the pleural exudate samples). The binding affinity constant (M-1 x 10(-4] was comparable for plasma (3.67), synovial fluid (4.14), and lymph (3.40), but was lower for ascites (2.37) and pleural fluid (range of 2.77 to 0.31). Plasma samples diluted with plasma water (range of 100 to 3%) exhibited a common affinity constant (mean value 4.03 x 10(4) M-1) and capacity constants which correlated directly with albumin concentration (r2 = 0.998, p less than 0.001). Analysis of these observations suggests that extravascular binding of ceftriaxone can readily be predicted if extravascular albumin concentration and corresponding disease-state plasma protein binding are known.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3411461     DOI: 10.1002/jps.2600770509

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients.

Authors:  Nicolas Simon; Bertrand Dussol; Emmanuelle Sampol; Raj Purgus; Philippe Brunet; Bruno Lacarelle; Yvon Berland; Bernard Bruguerolle; Saïk Urien
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Effect of protein binding on penetration of beta-lactams into rabbit peripheral lymph.

Authors:  G Woodnutt; V Berry; L Mizen
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

3.  Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.

Authors:  C Sauve; E Azoulay-Dupuis; P Moine; C Darras-Joly; V Rieux; C Carbon; J P Bédos
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

4.  Pharmacokinetics and protein binding of ceftriaxone during pregnancy.

Authors:  P Bourget; H Fernandez; V Quinquis; C Delouis
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

5.  Prediction of Unbound Ceftriaxone Concentration in Children: Simple Bioanalysis Method and Basic Mathematical Equation.

Authors:  Min Kan; Hai-Yan Shi; Zhong-Guo Sui; Wei Zhao; Bing Han; Yue-E Wu; Qian Li; Zi-Xuan Guo; Xue Li; Guo-Xiang Hao; Yi Zheng; Le-Qun Su; Xin Huang
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

6.  In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.

Authors:  P Moine; E Vallée; E Azoulay-Dupuis; P Bourget; J P Bédos; J Bauchet; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  Ceftriaxone disposition in open-heart surgery patients.

Authors:  G L Jungbluth; M T Pasko; T R Beam; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

8.  Population Pharmacokinetic Study of Ceftriaxone in Elderly Patients, Using Cystatin C-Based Estimates of Renal Function To Account for Frailty.

Authors:  Shu Jin Tan; Matthew Cockcroft; Sam Salman; Laurens Manning; Madhu Page-Sharp; Glenn Arendts; Timothy M E Davis; Brioni R Moore; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

9.  Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion.

Authors:  Perrin Ngougni Pokem; Xavier Wittebole; Christine Collienne; Hector Rodriguez-Villalobos; Paul M Tulkens; Laure Elens; Françoise Van Bambeke; Pierre-François Laterre
Journal:  Antibiotics (Basel)       Date:  2022-07-05

10.  Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort Study.

Authors:  Matthias Gijsen; Erwin Dreesen; Ruth Van Daele; Pieter Annaert; Yves Debaveye; Joost Wauters; Isabel Spriet
Journal:  Antibiotics (Basel)       Date:  2021-05-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.